DrugPatentWatch Database Preview
Msd Merck Co Company Profile
What is the competitive landscape for MSD MERCK CO, and when can generic versions of MSD MERCK CO drugs launch?
MSD MERCK CO has seven approved drugs.
There are three US patents protecting MSD MERCK CO drugs.
There are one hundred and forty-two patent family members on MSD MERCK CO drugs in forty-six countries and thirty-two supplementary protection certificates in eleven countries.
Summary for Msd Merck Co
| International Patents: | 142 |
| US Patents: | 3 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Msd Merck Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Merck Co | SINGULAIR | montelukast sodium | TABLET, CHEWABLE;ORAL | 020830-001 | Feb 20, 1998 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Msd Merck Co | SINGULAIR | montelukast sodium | TABLET;ORAL | 020829-002 | Feb 20, 1998 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Msd Merck Co | DELSTRIGO | doravirine; lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 210807-001 | Aug 30, 2018 | RX | Yes | Yes | 8,486,975 | Start Trial | Y | Y | Start Trial | ||
| Msd Merck Co | RECARBRIO | cilastatin sodium; imipenem; relebactam | POWDER;INTRAVENOUS | 212819-001 | Jul 16, 2019 | RX | Yes | Yes | 8,487,093 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Msd Merck Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-004 | Dec 23, 1991 | 4,444,784*PED | Start Trial |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-001 | Dec 23, 1991 | 4,444,784*PED | Start Trial |
| Msd Merck Co | EMEND | aprepitant | FOR SUSPENSION;ORAL | 207865-001 | Dec 17, 2015 | 6,096,742 | Start Trial |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-002 | Dec 23, 1991 | RE36481*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for MSD MERCK CO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsule | 40 mg, 80 mg and 125 mg | ➤ Subscribe | 2008-11-03 |
| ➤ Subscribe | Injection | 150 mg/vial | ➤ Subscribe | 2012-01-25 |
| ➤ Subscribe | Tablets | 10 mg | ➤ Subscribe | 2007-02-20 |
| ➤ Subscribe | Injection | 115 mg/vial | ➤ Subscribe | 2012-01-25 |
| ➤ Subscribe | for Oral Suspension | 125 mg/Kit | ➤ Subscribe | 2016-11-23 |
| ➤ Subscribe | Chewable Tablets | 4 mg and 5 mg | ➤ Subscribe | 2006-12-26 |
International Patents for Msd Merck Co Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Serbia | 55505 | Start Trial |
| Malaysia | 163979 | Start Trial |
| Taiwan | 201139409 | Start Trial |
| Ecuador | SP045144 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Msd Merck Co Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2552902 | PA2019506 | Lithuania | Start Trial | PRODUCT NAME: DORAVIRINAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/18/1332 20181122 |
| 0748320 | 08C0019 | France | Start Trial | PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111 |
| 2552902 | 122019000038 | Germany | Start Trial | |
| 0734381 | PA2004002,C0734381 | Lithuania | Start Trial | PRODUCT NAME: 5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUORMETIL)FENIL)ETOKSI)-3-(4-FLUORFENIL)-4-MORFOLINIL)METIL)-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO/DATE: EU/1/03/262/001, 2003 11 11, EU/1/03/262/002, 2003 11 11, EU/1/03/262/003, 2003 11 11, EU/1/03/262/004, 2003 11 11, EU/1/03/262/005, 2003 11 11, EU/1/03/262/006 20031111 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
